Yin, Xianyong http://orcid.org/0000-0001-6454-2384
Chan, Lap Sum http://orcid.org/0000-0003-3206-9064
Bose, Debraj http://orcid.org/0000-0002-3177-6608
Jackson, Anne U. http://orcid.org/0000-0002-9672-2547
VandeHaar, Peter http://orcid.org/0000-0002-8072-9461
Locke, Adam E. http://orcid.org/0000-0001-6227-198X
Fuchsberger, Christian
Stringham, Heather M. http://orcid.org/0000-0002-2991-6392
Welch, Ryan http://orcid.org/0000-0001-6378-1295
Yu, Ketian http://orcid.org/0000-0001-9994-3399
Fernandes Silva, Lilian http://orcid.org/0000-0003-0225-842X
Service, Susan K.
Zhang, Daiwei http://orcid.org/0000-0002-5019-622X
Hector, Emily C. http://orcid.org/0000-0003-1488-3150
Young, Erica http://orcid.org/0000-0002-3671-211X
Ganel, Liron http://orcid.org/0000-0002-8762-622X
Das, Indraniel
Abel, Haley
Erdos, Michael R. http://orcid.org/0000-0002-6603-1833
Bonnycastle, Lori L.
Kuusisto, Johanna
Stitziel, Nathan O. http://orcid.org/0000-0002-4963-8211
Hall, Ira M. http://orcid.org/0000-0003-4442-6655
Wagner, Gregory R.
Ripatti, Samuli http://orcid.org/0000-0002-0504-1202
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Kang, Jian
Morrison, Jean http://orcid.org/0000-0003-4829-8283
Burant, Charles F.
Collins, Francis S.
Ripatti, Samuli http://orcid.org/0000-0002-0504-1202
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Freimer, Nelson B. http://orcid.org/0000-0003-3586-6587
Mohlke, Karen L. http://orcid.org/0000-0001-6721-153X
Scott, Laura J. http://orcid.org/0000-0002-4886-5084
Wen, Xiaoquan http://orcid.org/0000-0001-8990-2737
Fauman, Eric B. http://orcid.org/0000-0002-9739-0249
Laakso, Markku http://orcid.org/0000-0002-3394-7749
Boehnke, Michael http://orcid.org/0000-0002-6442-7754
,
Funding for this research was provided by:
American Diabetes Association
Article History
Received: 13 August 2021
Accepted: 23 February 2022
First Online: 28 March 2022
Competing interests
: A.E.L. is an employee and stockholder of Regeneron Pharmaceuticals. L.G. is an employee of Genentech, Inc. and stockholder of Roche. N.O.S. has received research funding from Regeneron Pharmaceuticals unrelated to this work. G.R.W. is a stockholder of Metabolon, Inc. E.B.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.